Jack Lawler

Jack Lawler is the Senior Vice President of Global Clinical Development Operations at Chemomab Therapeutics. He joined the company in January 2022 as Vice President of Global Clinical Development Operations.12

Key points about Jack Lawler:

Professional Experience

• Over 22 years of clinical drug development experience1
• Contributed to the development of eight approved drugs1
• Previously served on the senior leadership team at Goldfinch Bio as Vice President of Clinical Operations and Data Management2

Role at Chemomab Therapeutics

• Responsible for overseeing global clinical development operations
• Based in the United States1
• Joined Chemomab to help advance their clinical programs, particularly for their lead candidate CM-101

Expertise

• Extensive background in clinical trial management and operations
• Experience in data management for clinical studies
• Track record of successful drug development across multiple therapeutic areas

Jack Lawler's appointment at Chemomab Therapeutics reflects the company's focus on strengthening its clinical development capabilities and advancing its pipeline of innovative therapeutics for fibrotic and inflammatory diseases.